Search - tctmd.com

Displaying 81 - 100 of 201

Sort: Relevancy | Date

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for November 2017

Shelley Wood

November 29, 2017

News Features

Trajectory Unknown: How ORBITA Lands in Clinical Practice Still Up for Debate

Michael O'Riordan

November 27, 2017

News Conference News TCT 2017

FAME 2 at 3 Years: Outcomes, Symptoms Better With PCI vs OMT in Stable CAD, at Similar Cost

L.A. McKeown

November 02, 2017

Presentation Stanford Coronary Physiology Conference 2017

iFR for Serial Lesion and Post PCI

Presenter: Habib Samady

October 28, 2017

Presentation Stanford Coronary Physiology Conference 2017

Data Supporting Microvascular Assessment

Presenter: William F. Fearon

October 28, 2017

Presentation Stanford Coronary Physiology Conference 2017

Derivation and Validation of Fractional Flow Reserve

Presenter: William F. Fearon

October 28, 2017

Presentation iASSESS 2017

FFR, CFR, and PCI

Presenter: Arnold Seto

August 30, 2017

News Conference News EuroPCR 2017

FFR-SEARCH Explores Potential of Physiologic Assessment After PCI

Caitlin E. Cox

May 18, 2017

News Conference News EuroPCR 2017

EuroPCR 2017: New Stents, New Questions for PCI Today and Tomorrow as Angioplasty Turns 40

Shelley Wood

May 12, 2017

News Conference News ACC 2017

CMR Perfusion Imaging Holds Its Own Against Invasive Approach to Managing Stable Angina

Todd Neale

March 22, 2017

News Conference News ACC 2017

FFR-Guided Complete Revascularization Tops PCI of Culprit Artery Alone in Acute STEMI

Todd Neale

March 18, 2017

News Conference News ACC 2017

iFR Matches FFR for Clinical Outcomes in Patients With Intermediate Lesions

Caitlin E. Cox

March 18, 2017

Presentation CHIP Florida 2017

Is PCI Overused?

Presenter: Ajay J. Kirtane

January 21, 2017

News Daily News

Registry Hints Staged Intervention Reduces Mortality in STEMI Patients With Multivessel CAD, but Controversy Remains

L.A. McKeown

January 09, 2017

News Conference News AHA 2016

Shaky FUTURE? FFR Takes a Hit With Mortality Signal in French Study

Michael O'Riordan

November 14, 2016

Presentation Cardiovascular Interventions 2016

Precision PCI

Presenter: Richard Shlofmitz

November 11, 2016

Presentation Cardiovascular Interventions 2016

PCI for STEMI: Fix the Culprit Lesion, or Fix All of the Lesions

Presenter: James Hermiller

November 08, 2016

Presentation Stanford Coronary Physiology Conference 2016

Will FFR-Directed PCI Be Better Than CABG? Update on the FAME 3 trial

Presenter: William F. Fearon

October 28, 2016

Presentation Stanford Coronary Physiology Conference 2016

FFR-Guided PCI Vs Medical Therapy: FAME 2 and Substudies

Presenter: Bernard De Bruyne

October 28, 2016

Presentation Stanford Coronary Physiology Conference 2016

Safety Of Deferring PCI Based Upon FFR: The DEFER Trial and Observational Data

Presenter: William F. Fearon

October 28, 2016

Advertisement

TCTMD’s Top 10 Most Popular Stories for November 2017

Trajectory Unknown: How ORBITA Lands in Clinical Practice Still Up for Debate

FAME 2 at 3 Years: Outcomes, Symptoms Better With PCI vs OMT in Stable CAD, at Similar Cost

iFR for Serial Lesion and Post PCI

Data Supporting Microvascular Assessment

Derivation and Validation of Fractional Flow Reserve

FFR, CFR, and PCI

FFR-SEARCH Explores Potential of Physiologic Assessment After PCI

EuroPCR 2017: New Stents, New Questions for PCI Today and Tomorrow as Angioplasty Turns 40

CMR Perfusion Imaging Holds Its Own Against Invasive Approach to Managing Stable Angina

FFR-Guided Complete Revascularization Tops PCI of Culprit Artery Alone in Acute STEMI

iFR Matches FFR for Clinical Outcomes in Patients With Intermediate Lesions

Is PCI Overused?

Registry Hints Staged Intervention Reduces Mortality in STEMI Patients With Multivessel CAD, but Controversy Remains

Shaky FUTURE? FFR Takes a Hit With Mortality Signal in French Study

Precision PCI

PCI for STEMI: Fix the Culprit Lesion, or Fix All of the Lesions

Will FFR-Directed PCI Be Better Than CABG? Update on the FAME 3 trial

FFR-Guided PCI Vs Medical Therapy: FAME 2 and Substudies

Safety Of Deferring PCI Based Upon FFR: The DEFER Trial and Observational Data

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content